Insider Buying and Selling - ZNTL

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
04/30/2025	04/30/2025	Myers Scott Dunseth Director	Buy	21,000 @ $1.40	$29,372.70	281,192	(8.07%)	Direct
02/06/2025	02/12/2025	Bruns Ingmar Chief Medical Officer Officer	Buy	20,000 @ $2.28	$45,656.00	36,629	(120.27%)	Direct
02/03/2025	02/05/2025	Lackner Mark Chief Scientific Officer Officer	Sell	-14,368 @ $1.71	($24,590.83)	512,856	(-2.73%)	Direct
02/03/2025	02/05/2025	Paul Andrea Chief Legal Officer Officer	Sell	-13,230 @ $1.71	($22,643.15)	1,070,784	(-1.22%)	Direct
02/03/2025	02/05/2025	Vultaggio Vincent PAO and Interim PFO Officer	Sell	-2,615 @ $1.71	($4,475.57)	189,826	(-1.36%)	Direct
01/31/2025	02/04/2025	Eastland Julia Marie CEO & President CEO Director	Buy	28,500 @ $1.73	$49,344.90	28,500	(100.00%)	Direct
01/31/2025	02/04/2025	Skvarka Jan Director	Buy	60,000 @ $1.72	$103,446.00	149,551	(67.00%)	Direct
01/31/2025	02/04/2025	Walker Luke Nathaniel Director	Buy	14,200 @ $1.76	$24,966.44	86,681	(19.59%)	Direct
01/02/2025	01/03/2025	Lackner Mark Chief Scientific Officer Officer	Sell	-4,411 @ $3.12	($13,762.32)	191,317	(-2.25%)	Direct
10/04/2024 10b5-1	10/04/2024	Vultaggio Vincent Principal Accounting Officer Officer	Sell	-1,603 @ $3.18	($5,097.54)	33,855	(-4.52%)	Direct

Zentalis Pharmaceuticals, Inc. - ZNTL